Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) comprises around 6% of all non-Hodgkin’s lymphoma (NHL) diagnoses. In younger patients, age less than 60 to 65 years, aggressive induction often followed by consolidation with autologous stem cell transplant has suggested improved outcomes in this population. Less intensiv...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Natl Cancer Inst
Main Authors: Spurgeon, Stephen E., Till, Brian G., Martin, Peter, Goy, Andre H., Dreyling, Martin P., Gopal, Ajay K., LeBlanc, Michael, Leonard, John P., Friedberg, Jonathan W., Baizer, Lawrence, Little, Richard F., Kahl, Brad S., Smith, Mitchell R.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Reviews
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059122/
https://ncbi.nlm.nih.gov/pubmed/28040733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw263
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki